169 related articles for article (PubMed ID: 37511561)
21. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
22. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
23. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
24. Enhanced binding of tissue factor-microparticles to collagen-IV and fibronectin leads to increased tissue factor activity in vitro.
Ettelaie C; Collier ME; Mei MP; Xiao YP; Maraveyas A
Thromb Haemost; 2013 Jan; 109(1):61-71. PubMed ID: 23152142
[TBL] [Abstract][Full Text] [Related]
25. Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation.
Collier ME; Ettelaie C
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1810-7. PubMed ID: 20616308
[TBL] [Abstract][Full Text] [Related]
26. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.
Bastarache JA; Fremont RD; Kropski JA; Bossert FR; Ware LB
Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1035-41. PubMed ID: 19700643
[TBL] [Abstract][Full Text] [Related]
27. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity.
Chiva-Blanch G; Laake K; Myhre P; Bratseth V; Arnesen H; Solheim S; Badimon L; Seljeflot I
PLoS One; 2017; 12(2):e0172558. PubMed ID: 28207887
[TBL] [Abstract][Full Text] [Related]
28. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation.
Kobayashi K; Baba K; Igase M; Miyama TS; Kambayashi S; Okuda M
J Vet Med Sci; 2020 Jan; 82(1):56-60. PubMed ID: 31787663
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Daly L; Bonnar J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
[TBL] [Abstract][Full Text] [Related]
30. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
[TBL] [Abstract][Full Text] [Related]
31. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
32. Tissue-factor-bearing microparticles (MPs-TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs-TF generation.
Świtońska M; Słomka A; Sinkiewicz W; Żekanowska E
Eur J Neurol; 2015 Feb; 22(2):395-401, e28-9. PubMed ID: 25370815
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor.
Collier ME; Ettelaie C
J Biol Chem; 2011 Apr; 286(14):11977-84. PubMed ID: 21310953
[TBL] [Abstract][Full Text] [Related]
34. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
[TBL] [Abstract][Full Text] [Related]
36. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
Prasad RN; Koh S; Ratnam SS
Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
[TBL] [Abstract][Full Text] [Related]
37. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
38. Tissue factor procoagulant activity in the tumor cell lines and plasma of dogs with various malignant tumors.
Kobayashi K; Baba K; Igase M; Primarizky H; Nemoto Y; Shimokawa Miyama T; Kambayashi S; Mizuno T; Okuda M
J Vet Med Sci; 2019 Dec; 81(12):1713-1721. PubMed ID: 31611484
[TBL] [Abstract][Full Text] [Related]
39. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
[TBL] [Abstract][Full Text] [Related]
40. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus.
Diamant M; Nieuwland R; Pablo RF; Sturk A; Smit JW; Radder JK
Circulation; 2002 Nov; 106(19):2442-7. PubMed ID: 12417540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
